# Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction

> **NCT00398632** · PHASE4 · TERMINATED · sponsor: **Stanford University** · enrollment: 6 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT00398632
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Unable to recruit subjects
- **Last updated:** 2017-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398632, "Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00398632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*